HarishLavuMD
General Surgery • Philadelphia, PAHepatobiliary Surgery, Surgical Oncology (Other than Breast)
Section Chief Hepatopancreatobiliary Surgery, Associate Professor, Jefferson Medical College-Thos Jefferson Univ
Dr. Lavu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
615 Chestnut St
Philadelphia, PA 19106Phone+1 215-955-2141Fax+1 215-955-2420
Summary
- Dr. Harish Lavu is a general surgeon in Philadelphia, PA and is affiliated with Thomas Jefferson University Hospitals. He received his medical degree from Albany Medical College and has been in practice 17 years. He specializes in hepatobiliary surgery and surgical oncology (other than breast) and is experienced in minimally invasive surgery, surgical oncology (non-breast), general / gastrointestinal surgery, and hepatopancreatobiliary surgery.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Surgery, 2000 - 2007
Albany Medical CollegeClass of 2000
Certifications & Licensure
CA State Medical License 2002 - Present
PA State Medical License 2008 - 2024
IN State Medical License 2007 - 2009- American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011-2012
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Intraoperative Celiac Plexus Neurolysis for Patients With Operable Pancreatic and Periampullary Cancer Start of enrollment: 2008 Sep 01
- The Use of a Restrictive Fluid Regimen With Hypertonic Saline for Patients Undergoing Pancreaticoduodenectomy Start of enrollment: 2011 May 01
- Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer Start of enrollment: 2013 May 01
- Join now to see all
Publications & Presentations
PubMed
- 38 citationsHost IDO2 gene status influences tumor progression and radiotherapy response in KRAS-driven sporadic pancreatic cancersAvinoam Nevler, Alexander J. Muller, Erika Sutanto-Ward, James B. DuHadaway, Kei Nagatomo
Clinical Cancer Research. 2019-01-15 - 6 citationsIntraductal Papillary Mucinous Neoplasm of the Pancreas Arising in the Setting of an Intermixed Acinar Cell Cystadenoma of the Pancreas: Report of a Rare Case.Benjamin B Scott, Thea P. Price, Zachary M. Callahan, Justin Poling, Harish Lavu
Case Reports in Pancreatic Cancer. 2016-12-01 - 128 citationsBenchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome Comparisons.Patricia Sánchez-Velázquez, Xavier Muller, Giuseppe Malleo, Joon-Seong Park, Ho-Kyoung Hwang
Annals of Surgery. 2019-08-01
Authored Content
- A Sub-Type of Familial Pancreatic Cancer: Evidence and Implications of Loss of Function Polymorphisms and Indoleamine-2,3-Dioxygenase-2February 2018
Press Mentions
New Recovery Pathway Could Speed up Time to Next Treatment for Pancreatic Cancer PatientsJanuary 25th, 2019
Saltier Intravenous Fluids Reduce Complications from Surgery, Study ShowsJuly 15th, 2014- Whipple Procedure Wound Infections Cut in Half with New MeasuresOctober 26th, 2011
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
